Peptide Hormones

Hormones synthesized from amino acids. They are distinguished from INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS in that their actions are systemic.
DrugDrug NameDrug Indication
DB00007LeuprolideFor treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty
DB00010SermorelinFor the treatment of dwarfism, prevention of HIV-induced weight loss
DB00014GoserelinGoserelin is indicated for: - Use in combination with flutamide for the management of locally confined carcinoma of the prostate - Palliative treatment of advanced carcinoma of the prostate - The management of endometriosis - Use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding - Use in the palliative treatment of advanced breast cancer in pre- and perimenopausal women
DB00017Salmon CalcitoninUsed in the treatment of symptomatic Paget's disease for patients unresponsive to alternate treatments or intolerant to such treatments. In addition, it is used in emergency situations when serum calcium levels must be decreased quickly until the underlying condition is identified. It can also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or corticosteroids, or other agents. Calcitonin can be used in patients with azotemia and cases where intravenous fluids would be contraindicated due to limited cardiac reserves. Also for the treatment of post-menopausal osteoporosis in women more than 5 years post-menopause.
DB00024Thyrotropin alfaFor detection of residueal or recurrent thyroid cancer
DB00030Insulin HumanHuman insulin is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
DB00032MenotropinsFor the treatment of female infertility
DB00035Desmopressin- Indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void (intranasal). - Indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region (intranasal/parenteral). - Indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5% or mild to moderate classic von Willebrand's Disease (Type I) with factor VIII levels greater than 5% during surgical procedures and postoperatively to maintain hemostasis (parenteral).
DB00040GlucagonFor treatment of severe hypoglycemia, also used in gastrointestinal imaging
DB00046Insulin LisproInsulin lispro is indicated to improve glycemic control in adults and children with diabetes mellitus.
DB00047Insulin glargineInsulin glargine is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
DB00050CetrorelixFor the inhibition of premature LH surges in women undergoing controlled ovarian stimulation
DB00052SomatotropinFor treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss
DB00066FollitropinIn women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).
DB00067VasopressinFor the treatment of enuresis, polyuria, diabetes insipidus, polydipsia and oesophageal varices with bleeding
DB00071Insulin PorkFor the treatment of type I and II diabetes mellitus.
DB00082PegvisomantPegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.
DB00093FelypressinFor use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.
DB00094UrofollitropinFor treatment of female infertility
DB00107OxytocinUsed for labor induction, augmentation of labor, postpartum abbreviation of third stage of labor, postpartum control of uterine bleeding, termination of pregnancy and for the evaluation of fetal respiratory capability. Oxytocin cannot be used for elective induction of labor, there must be a clear medical requirement.
DB00183PentagastrinUsed as a diagnostic aid for evaluation of gastric acid secretory function
DB00644GonadorelinFor evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.
DB00666NafarelinFor treatment of central precocious puberty (true precocious puberty, GnRH-dependent precocious precocity, complete isosexual precocity) in children of both sexes and for the treatment of endometriosis.
DB01278PramlintideFor the treatment of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy.
DB01282CarbetocinUsed to control postpartum hemorrhage and bleeding after giving birth.
DB01284TetracosactideFor use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.
DB01285CorticotropinFor use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.
DB01306Insulin AspartInsulin aspart is indicated to improve glycemic control in adults and children with diabetes mellitus.
DB01307Insulin DetemirInsulin detemir is indicated to improve glycemic control in adults and children with diabetes mellitus.
DB01309Insulin GlulisineInsulin glulisine is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
DB02638TerlipressinCommonly used to stop bleeding of varices in the food pipe (oesophagus).
DB04894VapreotideFor the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and has also shown efficacy in the treatment of patients with AIDS-related diarrhea.
DB04899NesiritideFor the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.
DB04900ThymalfasinIndicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to achieve adequate antibody titers from previous immunization.
DB04914G17DTIntended for the treatment of various forms of cancer.
DB04931AfamelanotideInvestigated for use/treatment in actinic keratosis, keratoses, skin cell studies, and skin infections/disorders.
DB05034UlaritideInvestigated for use/treatment in congestive heart failure.
DB05084AbaloparatideInvestigated for use/treatment in postmenopausal osteoporosis to reduce vertebral and/or non-vertebral fractures.
DB05098LeptinInvestigated for use/treatment in lipodystrophy and obesity.
DB05115NN344Investigated for use/treatment in diabetes mellitus type 1 and 2.
DB05394CorticorelinInvestigated for use/treatment in brain cancer and neurologic disorders.
DB05819NBI-6024Investigated for use/treatment in diabetes mellitus type 1 and pediatric indications.
DB05829Parathyroid hormoneFor use/treatment in osteoporosis.
DB06260AviptadilNot Available
DB06285TeriparatideFor the treatment of osteoporosis in men and postmenopausal women who are at high risk for having a fracture. Also used to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture.
DB06645AnamorelinInvestigated for use/treatment in cachexia and anorexia.
DB06655LiraglutideLiraglutide is indicated in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus[Label]. It is also indicated to reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus as well as cardiovascular disease[Label].
DB06663PasireotideFor the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery has not been curative or is not an option.
DB06719BuserelinBuserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.
DB06763SaralasinNot Available
DB06785GanirelixFor the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.
DB06788HistrelinAs the product Supprelin LA (FDA), histrelin is indicated for the treatment of children with central precocious puberty (CPP). As the product Vantas (FDA), histrelin is indicated for the palliative treatment of advanced prostate cancer.
DB06791LanreotideLanreotide is a somatostatin analog approved for treatment of neuroendocrine tumours and acromegaly. (2)
DB06825TriptorelinTriptorelin is indicated for the palliative treatment of advanced prostate cancer.
DB08869TesamorelinTesamorelin acetate is a synthetic analogue of human hypothalamic Growth Hormone Releasing Factor (hGRF) indicated to induce and maintain a reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.
DB08900TeduglutideTreatment of short bowel syndrome (SBS), malabsorption associated with the removal of the intestine, in adults patients who are dependent on parenteral support.
DB09043AlbiglutideIndicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
DB09045DulaglutideIndicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
DB09046MetreleptinMetreleptin is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
DB09059AtosibanAtosiban is indicated for use in delaying imminent pre-term birth in pregnant adult women with: - regular uterine contractions of at least 30 s duration at a rate of at least 4 per 30 min - a cervical dilation of 1-3cm (0-3cm for nulliparas) and effacement of at least 50% - a gestational age of 24-33 weeks - a normal fetal heart rate
DB09066Corifollitropin alfaControlled ovarian stimulation [L2273] in cases of women who are undergoing fertility treatment to stimulate the development of more than one mature egg simultaneously in the ovaries in combination with a gonadotrophin-releasing hormone (GnRH) antagonist (a type of medicine also used in fertility treatments)[L2270].
DB09067Corticorelin ovine triflutateCorticorelin is indicated for use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.
DB09098SomatremSomatrem is a recombinant human growth hormone indicated for: (a) treatment of paediatric patients with growth failure due to growth hormone deficiency (GHD), (b) treatment of paediatric patients with growth failure due to idiopathic short stature (ISS), (c) treatment of paediatric patients with growth failure due to Turner syndrome (TS), (d) treatment of paediatric patients with growth failure due to chronic kidney disease (CKD) up to the time of renal transplantation, (e) treatment of adults with childhood-onset GHD, or (f) treatment of adults with adult-onset GHD [FDA Label].
DB09099SomatostatinFor the symptomatic treatment of acute bleeding from esophageal varices. Other treatment options for long-term management of the condition may be considered if necessary, once initial control has been established.
DB09126Chorionic Gonadotropin (Human)For the treatment of prepubertal cryptorchidism (not due to anatomical obstruction), for the treatment of selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males and for the induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins.
DB09421ProtirelinNot Available
DB09527Secretin porcineNot Available
DB09564Insulin DegludecInsulin degludec is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
DB11510DeslorelinNot Available
DB11567Insulin peglisproNot Available
DB11653BremelanotideNot Available
DB11700SetmelanotideNot Available
DB11724BombesinNot Available
DB11777CenderitideNot Available
DB11842Angiotensin IIAngiotensin II is a vasoconstrictor indicated for increasing blood pressure in adults with septic or other distributive shock [FDA Label].
DB11895LenomorelinNot Available
DB11928VosoritideNot Available
DB12003Thymosin beta-4Not Available
DB12088TT-232Not Available
DB12495SelepressinNot Available
DB12602PentetreotideNot Available
DB12755Zoptarelin doxorubicinNot Available
DB12777SomatoprimNot Available
DB12822Pancreatic PolypeptideNot Available
DB13033Urocortin-2Not Available
DB13298AlsactideNot Available
DB13464OrnipressinNot Available
DB13517AngiotensinamideNot Available
DB13742ElcatoninNot Available
DB13798DemoxytocinNot Available
DB13928SemaglutideSemaglutide is indicated to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct of diet and exercise. The approved therapeutic doses are 0.5 mg and 1 mg.[L1068] Diabetes mellitus type 2 is a long-term metabolic disorder characterized by high blood sugar, insulin resistance and lack of insulin. Its onset is determined by the loss ability of beta cells to respond to an increased plasma glucose. This disease is predominantly caused by lifestyle factors like overweight and obesity. The key feature on type 2 diabetes is the presence of insulin resistance which reduced the capacity of insulin to exert its functions at normal at any given concentration. The secretion of insulin is stimulated by the action of incretins in the gut like glucagon-like peptide 1, which also delays gastric emptying and induces satiety, and glucose-dependent insulinotropic polypeptide.[T59]
DB14027TaspoglutideNot Available
DB09532Secretin humanIndicated for the stimulation of: - pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction [FDA Label]. - gastrin secretion to aid in the diagnosis of gastrinoma [FDA Label]. - pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP) [FDA Label].
DB14642LypressinNot Available
DB11835Indium In-111 pentetreotideNot Available
DB13170PlecanatidePlecanatide stimulates intestinal fluid secretions in the gastrointestinal tract to support regular bowel function. Plecanatide, taken orally once daily, works locally in the upper GI tract to stimulate secretion of intestinal fluid and support regular bowel function.
DB05004Peptide YY (3-36)Investigated for use/treatment in metabolic disease and obesity.
DB14741Luteinizing hormoneNot Available
DB14812ProcalcitoninNot Available
DB15093SomapacitanNot Available
DB15112Somatropin pegolNot Available
DB15217Gastric inhibitory polypeptideNot Available
DB15263ThyrotropinNot Available
DrugDrug NameTargetType
DB00007LeuprolideGonadotropin-releasing hormone receptortarget
DB00007LeuprolideCytochrome P450 3A4enzyme
DB00010SermorelinGrowth hormone-releasing hormone receptortarget
DB00014GoserelinLutropin-choriogonadotropic hormone receptortarget
DB00014GoserelinGonadotropin-releasing hormone receptortarget
DB00017Salmon CalcitoninCalcitonin receptortarget
DB00024Thyrotropin alfaThyrotropin receptortarget
DB00030Insulin HumanInsulin receptortarget
DB00030Insulin HumanRetinoblastoma-associated proteintarget
DB00030Insulin HumanInsulin-like growth factor 1 receptortarget
DB00030Insulin HumanInsulin-degrading enzymeenzyme
DB00030Insulin HumanNeuroendocrine convertase 2enzyme
DB00030Insulin HumanCarboxypeptidase Eenzyme
DB00030Insulin HumanNeuroendocrine convertase 1enzyme
DB00032MenotropinsFollicle-stimulating hormone receptortarget
DB00032MenotropinsLutropin-choriogonadotropic hormone receptortarget
DB00035DesmopressinVasopressin V1a receptortarget
DB00035DesmopressinVasopressin V1b receptortarget
DB00035DesmopressinVasopressin V2 receptortarget
DB00035DesmopressinProstaglandin G/H synthase 1enzyme
DB00035DesmopressinProstaglandin G/H synthase 2enzyme
DB00040GlucagonGlucagon receptortarget
DB00040GlucagonGlucagon-like peptide 2 receptortarget
DB00040GlucagonGlucagon-like peptide 1 receptortarget
DB00046Insulin LisproInsulin receptortarget
DB00046Insulin LisproInsulin-like growth factor 1 receptortarget
DB00047Insulin glargineInsulin receptortarget
DB00047Insulin glargineInsulin-like growth factor 1 receptortarget
DB00050CetrorelixLutropin-choriogonadotropic hormone receptortarget
DB00050CetrorelixGonadotropin-releasing hormone receptortarget
DB00052SomatotropinGrowth hormone receptortarget
DB00052SomatotropinProlactin receptortarget
DB00066FollitropinFollicle-stimulating hormone receptortarget
DB00067VasopressinVasopressin V1a receptortarget
DB00067VasopressinVasopressin V2 receptortarget
DB00067VasopressinVasopressin V1b receptortarget
DB00067VasopressinCanalicular multispecific organic anion transporter 1transporter
DB00071Insulin PorkInsulin receptortarget
DB00071Insulin PorkHLA class II histocompatibility antigen, DQ alpha 2 chaintarget
DB00071Insulin PorkHLA class II histocompatibility antigen, DQ beta 1 chaintarget
DB00071Insulin PorkRetinoblastoma-associated proteintarget
DB00071Insulin PorkCathepsin Dtarget
DB00071Insulin PorkInsulin-like growth factor 1 receptortarget
DB00071Insulin PorkInsulin-degrading enzymetarget
DB00071Insulin PorkNeuroendocrine convertase 2target
DB00071Insulin PorkCarboxypeptidase Etarget
DB00071Insulin PorkNeuroendocrine convertase 1target
DB00071Insulin PorkProtein NOV homologtarget
DB00071Insulin PorkLow-density lipoprotein receptor-related protein 2target
DB00071Insulin PorkInsulin-like growth factor-binding protein 7target
DB00071Insulin PorkSynaptotagmin-like protein 4target
DB00082PegvisomantGrowth hormone receptortarget
DB00082PegvisomantSterol 26-hydroxylase, mitochondrialenzyme
DB00082PegvisomantGlutamine synthetaseenzyme
DB00082PegvisomantCytochrome P450 2C18enzyme
DB00082PegvisomantCytochrome P450 3A4enzyme
DB00082PegvisomantCholinesteraseenzyme
DB00082PegvisomantCytochrome P450 2C19enzyme
DB00082PegvisomantCytochrome P450 4A11enzyme
DB00093FelypressinVasopressin V1a receptortarget
DB00094UrofollitropinFollicle-stimulating hormone receptortarget
DB00107OxytocinOxytocin-neurophysin 1target
DB00107OxytocinOxytocin receptortarget
DB00107OxytocinProlyl endopeptidaseenzyme
DB00183PentagastrinGastrin/cholecystokinin type B receptortarget
DB00183PentagastrinCholinesteraseenzyme
DB00644GonadorelinGonadotropin-releasing hormone receptortarget
DB00644GonadorelinPutative gonadotropin-releasing hormone II receptortarget
DB00666NafarelinGonadotropin-releasing hormone receptortarget
DB00666NafarelinPutative gonadotropin-releasing hormone II receptortarget
DB01278PramlintideReceptor activity-modifying protein 1target
DB01278PramlintideReceptor activity-modifying protein 2target
DB01278PramlintideReceptor activity-modifying protein 3target
DB01278PramlintideCalcitonin receptortarget
DB01282CarbetocinOxytocin receptortarget
DB01284TetracosactideAdrenocorticotropic hormone receptortarget
DB01285CorticotropinAdrenocorticotropic hormone receptortarget
DB01285CorticotropinCorticoliberintarget
DB01285Corticotropin3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2enzyme
DB01285Corticotropin25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialenzyme
DB01285Corticotropin1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialenzyme
DB01285CorticotropinCytochrome P450 3A4enzyme
DB01306Insulin AspartInsulin receptortarget
DB01306Insulin AspartInsulin-like growth factor 1 receptortarget
DB01307Insulin DetemirInsulin receptortarget
DB01307Insulin DetemirSerum albumincarrier
DB01307Insulin DetemirInsulin-like growth factor 1 receptortarget
DB01309Insulin GlulisineInsulin receptortarget
DB01309Insulin GlulisineInsulin-like growth factor 1 receptortarget
DB02638TerlipressinVasopressin V1a receptortarget
DB02638TerlipressinVasopressin V2 receptortarget
DB02638TerlipressinVasopressin V1b receptortarget
DB04894VapreotideSubstance-P receptortarget
DB04894VapreotideSomatostatin receptor type 2target
DB04894VapreotideSomatostatin receptor type 5target
DB04894VapreotideCytochrome P450 3A4enzyme
DB04899NesiritideAtrial natriuretic peptide receptor 1target
DB04899NesiritideAtrial natriuretic peptide receptor 2target
DB04899NesiritideAtrial natriuretic peptide receptor 3target
DB04931AfamelanotideMelanocyte-stimulating hormone receptortarget
DB05034UlaritideAtrial natriuretic peptide receptor 1target
DB05084AbaloparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB05098LeptinLeptin receptortarget
DB05115NN344Insulin receptortarget
DB05394CorticorelinDopamine beta-hydroxylaseenzyme
DB05829Parathyroid hormoneParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB05829Parathyroid hormoneParathyroid hormone 2 receptortarget
DB06285TeriparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB06655LiraglutideGlucagon-like peptide 1 receptortarget
DB06655LiraglutideDipeptidyl peptidase 4enzyme
DB06655LiraglutideNeprilysinenzyme
DB06655LiraglutideSerum albumincarrier
DB06663PasireotideSomatostatin receptor type 1target
DB06663PasireotideSomatostatin receptor type 2target
DB06663PasireotideSomatostatin receptor type 3target
DB06663PasireotideSomatostatin receptor type 5target
DB06663PasireotideCytochrome P450 3A4enzyme
DB06719BuserelinLutropin-choriogonadotropic hormone receptortarget
DB06719BuserelinGonadotropin-releasing hormone receptortarget
DB06719BuserelinCytochrome P450 19A1enzyme
DB06785GanirelixGonadotropin-releasing hormone receptortarget
DB06788HistrelinGonadotropin-releasing hormone receptortarget
DB06791LanreotideSomatostatin receptor type 2target
DB06791LanreotideSomatostatin receptor type 5target
DB06791LanreotideCytochrome P450 3A4enzyme
DB06825TriptorelinGonadotropin-releasing hormone receptortarget
DB08869TesamorelinGrowth hormone-releasing hormone receptortarget
DB08900TeduglutideGlucagon-like peptide 2 receptortarget
DB09043AlbiglutideGlucagon-like peptide 1 receptortarget
DB09045DulaglutideGlucagon-like peptide 1 receptortarget
DB09046MetreleptinLeptin receptortarget
DB09059AtosibanOxytocin receptortarget
DB09059AtosibanVasopressin V1a receptortarget
DB09059AtosibanVasopressin V1b receptortarget
DB09059AtosibanVasopressin V2 receptortarget
DB09066Corifollitropin alfaFollicle-stimulating hormone receptortarget
DB09067Corticorelin ovine triflutateCorticotropin-releasing factor receptor 1target
DB09098SomatremGrowth hormone receptortarget
DB09098SomatremInsulin-like growth factor 1 receptortarget
DB09099SomatostatinSomatostatin receptor type 1target
DB09099SomatostatinSomatostatin receptor type 2target
DB09099SomatostatinSomatostatin receptor type 3target
DB09099SomatostatinSomatostatin receptor type 4target
DB09099SomatostatinSomatostatin receptor type 5target
DB09099SomatostatinMultidrug resistance protein 1transporter
DB09099SomatostatinCytochrome P450 3A4enzyme
DB09126Chorionic Gonadotropin (Human)Lutropin-choriogonadotropic hormone receptortarget
DB09421ProtirelinThyrotropin Releasing Hormone Receptortarget
DB09564Insulin DegludecInsulin receptortarget
DB09564Insulin DegludecInsulin-like growth factor 1 receptortarget
DB09564Insulin DegludecSerum albumincarrier
DB11842Angiotensin IIType-1 angiotensin II receptortarget
DB13928SemaglutideSerum albumincarrier
DB13928SemaglutideDipeptidyl peptidase 4enzyme
DB13928SemaglutideNeprilysinenzyme
DB13928SemaglutideGlucagon-like peptide 1 receptortarget
DB13928SemaglutideSolute carrier organic anion transporter family member 1B1transporter
DB13928SemaglutideSolute carrier organic anion transporter family member 1B3transporter
DB13928SemaglutideLipoprotein lipaseenzyme
DB13928SemaglutideAlpha-amylase 1enzyme
DB09532Secretin humanSecretin receptortarget
DB14642LypressinVasopressin V1a receptortarget
DB14642LypressinVasopressin V2 receptortarget
DB14642LypressinVasopressin V1b receptortarget
DB14642LypressinCanalicular multispecific organic anion transporter 1transporter
DB13170PlecanatideGuanylate cyclase soluble subunit alpha-2target
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 2target
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 1target
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 5target
DB05004Peptide YY (3-36)Neuropeptide Y receptor type 4target